The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman's risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three fold when compared to women not using a hormonal contraceptive, according to a study jointly funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health and the U.S. Agency for International Development's Office of Population and Reproductive Health.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Bone Loss in Depo-Provera Users Largely Reversible
A new study confirms earlier reports that Depo-Provera, an injectable contraceptive popular among young and low-income American women, is strongly associated with bone density loss.
NICHD Study Finds No Association Between Oral Contraceptive Use & Breast Cancer For Women from 35 to 64
Women between the ages of 35 and 64 who took oral contraceptives at some point in their lives are no more likely to develop breast cancer than are other women the same age, according to findings from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Women's Contraceptive and Reproductive Experiences Study (Women's CARE).
Few Women Regret Sterilization Procedures
Few of the women who undergo tubal sterilization or whose husbands undergo vasectomy later go on to regret either procedure, according to a study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and conducted by the Centers for Disease Control and Prevention (CDC).
Federal Funds Support Expansion of Research in Women's Health
In a major new effort to stimulate women's health research across a variety of disciplines, the National Institutes of Health announced it will fund 11 awards to support development of new research in women's health.
NICHD Study Shows Treatment Fails to Prevent Preterm birth
In the largest study of its kind, antibiotic treatment to eliminate bacterial vaginosis failed to prevent premature birth, according to a study supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and coauthored by researchers at the NICHD and several other institutions.
NIH Awards Additional Funding for New Researchers in Women's Reproductive Health
The National Institutes of Health (NIH) has awarded $3.2 million to fund centers that will support early research careers in the field of obstetrics and gynecology.
Four Million Dollars Awarded for New Researchers in Women’s Health
To help advance research in women's reproductive health, twelve centers have been awarded a total of $4 million to support early research careers in the field of obstetrics and gynecology.